NCT04257292
NExt-Generation Sequencing and Cell Culture-based Characterization of S. Aureus in Infective Endocarditis No drug interventions Not Available Not Available unknown_status NCT01160172
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults No drug interventions prevention 1 completed NCT00279864
The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection No drug interventions Not Available Not Available completed NCT00814151
MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial No drug interventions Not Available Not Available completed NCT00730028
Uncomplicated Skin and Soft Tissue Infections Caused by Community-Associated Methicillin-Resistant Staphylococcus Aureus treatment 2 completed NCT01827358
Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants prevention 2 completed NCT00735839
V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED) No drug interventions prevention 1 completed NCT02812446
Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development No drug interventions Not Available Not Available completed NCT01592214
Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73 No drug interventions treatment 1 completed NCT02899702
Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children treatment 4 withdrawn NCT00846105
Efficacy Study of Rapid Test to Prevent Hospital Transmission of Methicillin-Resistant Staphylococcus Aureus (MRSA) No drug interventions prevention Not Available completed NCT00729937
Strategies Using Off-Patent Antibiotics for Methicillin Resistant S. Aureus "STOP MRSA" treatment 2 / 3 completed NCT00770341
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002) treatment 3 completed NCT00352612
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections treatment 4 completed NCT02284555
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment) treatment 4 completed NCT06479837
Modeling Host-Pathogen Interaction Using Lymphoid Organoids No drug interventions Not Available Not Available recruiting NCT00736554
What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? No drug interventions Not Available Not Available completed NCT00859677
Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection No drug interventions Not Available Not Available completed NCT01364571
Evaluation of a Single Vaccination With One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years No drug interventions prevention 1 completed NCT01447407
Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine No drug interventions prevention 1 completed NCT00211900
Evaluation of Manufacturing Lot of StaphVAX No drug interventions prevention 3 completed NCT00211913
StaphVAX in Cardiovascular Surgery Patients No drug interventions prevention 3 completed NCT00646919
Preoperative Nasal Swabs From Pediatric Patients No drug interventions Not Available Not Available unknown_status NCT00217841
Aurograb and Vancomycin in MRSA Infection No drug interventions educational_counseling_training 3 completed NCT01018641
An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults No drug interventions prevention 1 completed NCT02492958
SA4Ag Safety, Tolerability, and Immunogenicity Study in Japanese Adults No drug interventions other 2 completed NCT01273922
Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida No drug interventions prevention 1 completed NCT02971657
Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients' Clinical Outcome in Orthopedic Device Related Bone Infections No drug interventions Not Available Not Available completed NCT01431326
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Not Available Not Available completed NCT00211926
StaphVAX Immunogenicity in Orthopedic Implant Patients No drug interventions prevention 3 completed NCT00631566
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons treatment Not Available completed NCT02502474
Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne No drug interventions diagnostic Not Available completed NCT00423982
Rifampin Combination Therapy Versus Monotherapy in Early Staphylococcal Infections After Total Hip and Knee Arthroplasty treatment 4 unknown_status NCT00518076
Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant No drug interventions Not Available Not Available unknown_status NCT00130260
Evaluation of a Third and Fourth Dose of StaphVAX® in Adults With End-Stage Renal Disease No drug interventions prevention 3 terminated NCT00113191
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants No drug interventions prevention Not Available completed NCT00211991
Evaluation of Consistency of StaphVAX Manufacturing Lots No drug interventions prevention 3 completed NCT00419991
Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection treatment 4 completed NCT00066989
Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates prevention 2 completed NCT00063089
Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever treatment 1 / 2 completed NCT05899140
Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial treatment 4 not_yet_recruiting NCT02557568
Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne No drug interventions diagnostic Not Available completed NCT00303069
V710 First-In-Man (FIM) Study (V710-001) No drug interventions prevention 1 completed NCT00779246
Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections prevention Not Available completed NCT02595112
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery No drug interventions screening Not Available completed NCT00071214
Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis No drug interventions prevention 3 completed NCT00501150
Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections treatment Not Available completed NCT00620984
Staphylococcus Aureus Carrier Status in Breastfeeding Mothers and Infants and the Risk of Lactation Mastitis No drug interventions Not Available Not Available completed NCT04141787
Ceftriaxone as Home IV for Staph Infections treatment 4 unknown_status NCT00156377
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections prevention 4 completed NCT00509847
A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis treatment 1 / 2 withdrawn NCT00368498
A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely treatment 4 unknown_status NCT02782078
Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections treatment Not Available completed NCT02640937
Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections No drug interventions Not Available Not Available completed NCT01144000
Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection treatment 2 unknown_status NCT03915470
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection No drug interventions prevention 2 completed NCT00175370
Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus treatment Not Available completed NCT01643941
Evaluation of a Single Vaccination of One of Three Ascending Dose Levels of a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) and a Single Dose Level of a 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) in Healthy Adults Aged 65 to <86 Years No drug interventions prevention 1 completed NCT02364596
Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years No drug interventions prevention 1 completed NCT00211965
StaphVAX Immunogenicity and Safety in Orthopaedic Joint Surgery No drug interventions prevention 3 completed NCT00427076
Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections treatment 3 completed NCT00666276
Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan) Not Available Not Available completed NCT00108160
Preventing Staphylococcal (Staph) Infection prevention 4 completed NCT04409392
Staphylococcus Lugdunensis Prosthetic Joint Infection No drug interventions Not Available Not Available completed NCT03456544
Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China Not Available Not Available unknown_status NCT02664740
Standard Treatment Associated With Phage Therapy Versus Placebo for Diabetic Foot Ulcers Infected by S. Aureus No drug interventions treatment 1 / 2 unknown_status NCT01324440
Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) No drug interventions prevention 1 completed NCT01196169
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty prevention 4 terminated